Cargando…

Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study

RATIONALE & OBJECTIVE: Copeptin and Midrange pro-atrial natriuretic peptide (MR-pro-ANP) are associated with outcomes independently of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in patients with heart failure (HF). The value of these markers in patients with chronic kidney disease (CK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Markus P., Schmid, Matthias, Nadal, Jennifer, Krane, Vera, Saritas, Turgay, Busch, Martin, Schultheiss, Ulla T., Meiselbach, Heike, Friedrich, Nele, Nauck, Matthias, Floege, Jürgen, Kronenberg, Florian, Wanner, Christoph, Eckardt, Kai-Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616426/ https://www.ncbi.nlm.nih.gov/pubmed/37915964 http://dx.doi.org/10.1016/j.xkme.2023.100725

Ejemplares similares

Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort
por: Reimer, Katharina Charlotte, et al.
Publicado: (2023)

Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) Cohort
por: Winitzki, Doris, et al.
Publicado: (2022)

Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Correction: Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study
por: Beck, Hanna, et al.
Publicado: (2015)

Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study
por: Schneider, Markus P., et al.
Publicado: (2018)

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
por: Busch, Martin, et al.
Publicado: (2016)

Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort
por: Ruhe, Johannes, et al.
Publicado: (2023)

Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
por: Sommerer, Claudia, et al.
Publicado: (2023)

Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study
por: Schwaiger, Johannes P., et al.
Publicado: (2022)

Low adherence to CKD-specific dietary recommendations associates with impaired kidney function, dyslipidemia, and inflammation
por: Kaesler, Nadine, et al.
Publicado: (2021)

Validation of a Novel Predictive Algorithm for Kidney Failure in Patients Suffering from Chronic Kidney Disease: The Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD)
por: Bellocchio, Francesco, et al.
Publicado: (2021)

Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study
por: Mirna, Moritz, et al.
Publicado: (2020)

Left Ventricular Structure in Patients With Mild-to-Moderate CKD—a Magnetic Resonance Imaging Study
por: Schneider, Markus P., et al.
Publicado: (2018)

Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease
por: Saritas, Turgay, et al.
Publicado: (2019)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease
por: Gregorich, Mariella, et al.
Publicado: (2023)

The Cardiovascular Literature-Based Risk Algorithm (CALIBRA): Predicting Cardiovascular Events in Patients With Non-Dialysis Dependent Chronic Kidney Disease
por: Neri, Luca, et al.
Publicado: (2022)

Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women
por: Okwor, Chika J., et al.
Publicado: (2022)

Magnesium in CKD: more than a calcification inhibitor?
por: Floege, Jürgen
Publicado: (2014)

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
por: Kriechbaum, Steffen D., et al.
Publicado: (2020)

Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
por: Karakioulaki, Meropi, et al.
Publicado: (2021)

Brain natriuretic peptide among stroke patients
por: Saritas, Ayhan, et al.
Publicado: (2014)

Calcimimetics in CKD—results from recent clinical studies
por: Schlieper, Georg, et al.
Publicado: (2008)

Effects of exercise on serum ischemia-modified albumin, brain natriuretic peptide and copeptin levels in boxers and kick boxers
por: Memmedov, Hikmet, et al.
Publicado: (2022)

Copeptin: Limited Usefulness in Early Stroke Differentiation?
por: von Recum, Johannes, et al.
Publicado: (2015)

Associations between genetic risk variants for kidney diseases and kidney disease etiology
por: Wunnenburger, Sebastian, et al.
Publicado: (2017)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study
por: Kielstein, Jan T, et al.
Publicado: (2019)

Higher Serum Concentrations of N-Terminal Pro-B-Type Natriuretic Peptide Associate with Prevalent Hypertension whereas Lower Associate with Incident Hypertension
por: Seven, Ekim, et al.
Publicado: (2015)

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
por: Winkler, Karl, et al.
Publicado: (2008)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study
por: Schultheiss, Ulla T, et al.
Publicado: (2020)

Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
por: Marx, Nikolaus, et al.
Publicado: (2021)

Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study
por: Cheng, Yurong, et al.
Publicado: (2022)

Copeptin in aneurysmal subarachnoid hemorrhage
por: Tamargo, Rafael J
Publicado: (2012)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Copeptin analysis in endocrine disorders
por: Moodley, Nareshni
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k4ka8qadu2cv6pte6plabs5b1c